Bristol-Myers Squibb Company financial reports, Bristol-Myers Squibb Company annual revenue in 2024. When does Bristol-Myers Squibb Company report revenue?
Bristol-Myers Squibb Company total revenue, net income and dynamics of changes in US dollar today
The dynamics of Bristol-Myers Squibb Company net revenue grew by 5 000 000 $ compared to the previous report. Net income of Bristol-Myers Squibb Company today amounted to 2 021 000 000 $. These are the main financial indicators of Bristol-Myers Squibb Company. Graph of the financial report of Bristol-Myers Squibb Company. Information on Bristol-Myers Squibb Company net income on the chart on this page is drawn in blue bars. A graph of the value of all Bristol-Myers Squibb Company assets is presented in green bars.
Report date
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
31/03/2021
11 073 000 000 $
+87.04 % ↑
2 021 000 000 $
+18.19 % ↑
31/12/2020
11 068 000 000 $
+39.31 % ↑
-10 027 000 000 $
-
30/09/2020
10 540 000 000 $
+75.46 % ↑
1 872 000 000 $
+38.36 % ↑
30/06/2020
10 129 000 000 $
+61.47 % ↑
-85 000 000 $
-105.936 % ↓
31/12/2019
7 945 000 000 $
-
-1 056 000 000 $
-
30/09/2019
6 007 000 000 $
-
1 353 000 000 $
-
30/06/2019
6 273 000 000 $
-
1 432 000 000 $
-
31/03/2019
5 920 000 000 $
-
1 710 000 000 $
-
31/12/2018
5 973 000 000 $
-
1 160 000 000 $
-
30/09/2018
5 691 000 000 $
-
1 901 000 000 $
-
30/06/2018
5 704 000 000 $
-
373 000 000 $
-
31/03/2018
5 193 000 000 $
-
1 486 000 000 $
-
31/12/2017
5 449 000 000 $
-
-2 328 000 000 $
-
30/09/2017
5 254 000 000 $
-
845 000 000 $
-
30/06/2017
5 144 000 000 $
-
916 000 000 $
-
Show:
to
Bristol-Myers Squibb Company financial report charts
The latest dates of Bristol-Myers Squibb Company financial statements available online: 30/06/2017, 31/12/2020, 31/03/2021. Dates and dates of financial statements are established by the laws of the country where the company operates. The latest financial report of Bristol-Myers Squibb Company is available online for such a date - 31/03/2021. Gross profit Bristol-Myers Squibb Company is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit Bristol-Myers Squibb Company is 8 649 000 000 $
Bristol-Myers Squibb Company quarterly report dates
Cost of revenue Bristol-Myers Squibb Company is the total cost of producing and distributing of products and services of a company. Cost of revenue Bristol-Myers Squibb Company is 2 424 000 000 $ Total revenue Bristol-Myers Squibb Company refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue Bristol-Myers Squibb Company is 11 073 000 000 $ Operating income Bristol-Myers Squibb Company is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Bristol-Myers Squibb Company is 2 244 000 000 $
Net income Bristol-Myers Squibb Company is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Bristol-Myers Squibb Company is 2 021 000 000 $ Current assets Bristol-Myers Squibb Company is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Bristol-Myers Squibb Company is 27 111 000 000 $ Total assets Bristol-Myers Squibb Company refers to the total amount of assets owned by a person or entity. Total assets Bristol-Myers Squibb Company is 112 435 000 000 $
31/03/2021
31/12/2020
30/09/2020
30/06/2020
31/12/2019
30/09/2019
30/06/2019
31/03/2019
31/12/2018
30/09/2018
30/06/2018
31/03/2018
31/12/2017
30/09/2017
30/06/2017
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
8 649 000 000 $
8 833 000 000 $
8 497 000 000 $
8 158 000 000 $
6 138 000 000 $
4 219 000 000 $
4 420 000 000 $
4 088 000 000 $
4 301 000 000 $
4 055 000 000 $
4 093 000 000 $
3 609 000 000 $
3 776 000 000 $
3 682 000 000 $
3 582 000 000 $
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
2 424 000 000 $
2 235 000 000 $
2 043 000 000 $
1 971 000 000 $
1 807 000 000 $
1 788 000 000 $
1 853 000 000 $
1 832 000 000 $
1 672 000 000 $
1 636 000 000 $
1 611 000 000 $
1 584 000 000 $
1 673 000 000 $
1 572 000 000 $
1 562 000 000 $
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
11 073 000 000 $
11 068 000 000 $
10 540 000 000 $
10 129 000 000 $
7 945 000 000 $
6 007 000 000 $
6 273 000 000 $
5 920 000 000 $
5 973 000 000 $
5 691 000 000 $
5 704 000 000 $
5 193 000 000 $
5 449 000 000 $
5 254 000 000 $
5 144 000 000 $
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
-
-
-
-
7 945 000 000 $
6 007 000 000 $
6 273 000 000 $
5 920 000 000 $
5 973 000 000 $
5 691 000 000 $
5 704 000 000 $
4 972 000 000 $
5 046 000 000 $
4 862 000 000 $
4 770 000 000 $
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
2 244 000 000 $
1 248 000 000 $
2 039 000 000 $
2 026 000 000 $
1 427 000 000 $
1 810 000 000 $
2 078 000 000 $
1 788 000 000 $
1 634 000 000 $
1 690 000 000 $
1 621 000 000 $
1 390 000 000 $
485 000 000 $
970 000 000 $
720 000 000 $
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
2 021 000 000 $
-10 027 000 000 $
1 872 000 000 $
-85 000 000 $
-1 056 000 000 $
1 353 000 000 $
1 432 000 000 $
1 710 000 000 $
1 160 000 000 $
1 901 000 000 $
373 000 000 $
1 486 000 000 $
-2 328 000 000 $
845 000 000 $
916 000 000 $
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
2 225 000 000 $
2 579 000 000 $
2 273 000 000 $
2 129 000 000 $
1 955 000 000 $
1 362 000 000 $
1 284 000 000 $
1 300 000 000 $
1 358 000 000 $
1 262 000 000 $
1 341 000 000 $
1 250 000 000 $
1 921 000 000 $
1 543 000 000 $
1 659 000 000 $
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
8 829 000 000 $
9 820 000 000 $
8 501 000 000 $
8 103 000 000 $
6 518 000 000 $
4 197 000 000 $
4 195 000 000 $
4 132 000 000 $
4 339 000 000 $
4 001 000 000 $
4 083 000 000 $
2 219 000 000 $
3 291 000 000 $
2 712 000 000 $
2 862 000 000 $
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
27 111 000 000 $
30 192 000 000 $
34 277 000 000 $
34 343 000 000 $
-
40 191 000 000 $
37 716 000 000 $
17 093 000 000 $
17 160 000 000 $
14 869 000 000 $
13 874 000 000 $
14 649 000 000 $
14 854 000 000 $
15 048 000 000 $
14 324 000 000 $
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
112 435 000 000 $
118 481 000 000 $
125 536 000 000 $
128 076 000 000 $
-
57 433 000 000 $
55 163 000 000 $
34 834 000 000 $
34 986 000 000 $
33 734 000 000 $
32 641 000 000 $
33 083 000 000 $
33 551 000 000 $
33 977 000 000 $
33 409 000 000 $
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
10 982 000 000 $
14 546 000 000 $
19 435 000 000 $
19 934 000 000 $
-
30 489 000 000 $
28 404 000 000 $
7 335 000 000 $
6 911 000 000 $
5 408 000 000 $
4 999 000 000 $
5 342 000 000 $
5 421 000 000 $
4 644 000 000 $
3 470 000 000 $
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
-
-
-
-
-
10 489 000 000 $
9 711 000 000 $
8 841 000 000 $
10 654 000 000 $
9 694 000 000 $
9 878 000 000 $
1 925 000 000 $
987 000 000 $
1 461 000 000 $
1 306 000 000 $
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
-
-
-
-
-
-
-
-
-
-
-
6 770 000 000 $
6 812 000 000 $
7 122 000 000 $
6 505 000 000 $
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
-
-
-
-
-
39 679 000 000 $
39 012 000 000 $
19 517 000 000 $
20 859 000 000 $
19 984 000 000 $
20 223 000 000 $
7 700 000 000 $
7 962 000 000 $
8 443 000 000 $
8 217 000 000 $
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
-
-
-
-
-
69.09 %
70.72 %
56.03 %
59.62 %
59.24 %
61.96 %
23.27 %
23.73 %
24.85 %
24.60 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
37 605 000 000 $
37 822 000 000 $
50 158 000 000 $
49 094 000 000 $
17 648 000 000 $
17 648 000 000 $
16 049 000 000 $
15 218 000 000 $
14 031 000 000 $
13 640 000 000 $
12 317 000 000 $
12 793 000 000 $
11 741 000 000 $
14 783 000 000 $
14 699 000 000 $
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
-
-
-
-
-
2 556 000 000 $
2 083 000 000 $
1 390 000 000 $
2 429 000 000 $
1 279 000 000 $
1 057 000 000 $
1 175 000 000 $
1 117 000 000 $
1 713 000 000 $
1 584 000 000 $
Last revenue report of Bristol-Myers Squibb Company was 31/03/2021. According to last financial report total revenue in Bristol-Myers Squibb Company was 11 073 000 000 US dollar and changed by +87.04% since last year. Net income in Bristol-Myers Squibb Company was 2 021 000 000 $ in last quartal, net income changes to +18.19%.
Current cash Bristol-Myers Squibb Company - the sum of all of the cash a company has on the date of report. Current cash Bristol-Myers Squibb Company is 10 982 000 000 $
Bristol-Myers Squibb Company stocks data
BMY stock price
Bristol-Myers Squibb Company stock price today, BMY stock quote.
